Speaker: Thomas R. Frieden Presider: Jo Ivey Boufford
Thomas R. Frieden, director of U.S. Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry, discusses the challenges facing low- and middle-income countries in combating noncommunicable diseases.
This session is part one of the two session meeting, Noncommunicable Diseases and the New Global Health.
Dr. Thomas R. Frieden, Director, U.S. Centers for Disease Control and Prevention discusses the new set of global health challenges arising in low- and middle-income countries and the scalable, practical strategies that can help address them.
The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR's Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.
Why is the UN convening a summit-level meeting on illnesses like cancer and diabetes? This CFR guide looks at how these non-communicable diseases have amplified the burdens on developing states and the global threat they pose.
NCDs such as cancer and heart disease are becoming leading causes of death in the developing world and will be the focus of a September UN meeting. But health experts and others are divided about how much funding should go into a global campaign aimed at preventing NCDs and whether infectious disease programs will suffer as a result.
Amanda Glassman, director of Global Health Policy at the Center for Global Development, discusses the impact of non-communicable diseases (NCDs), strategies to reduce NDC occurence, and the failure to implement such interventions.
Derek Yach, director of global health policy at PepsiCo, discusses the role of government and business in lowering mortality rates from non-communicable diseases (NCDs). "We now have overwhelming evidence, both of the health impact, and perhaps as importantly, we're starting to see the economic impact of heart disease, diabites, chronic lung disease, cancer," says Yach, arguing this data is raising global interest in the issue of NCDs.
Authors: Sir George Alleyne, Alafia Samuels, and Karen Sealey
Sir George Alleyne, Alafia Samuels, and Karen Sealey explain the tensions between advocacy factions in the effort to reduce non-communicable diseases (and communicable diseases), and potential constructive resolutions.
As tobacco reemerges as a contentious issue in trade policy, CFR Senior Fellow Thomas Bollyky argues that the Obama administration can better balance U.S. mandates on tobacco trade policy with its interests in promoting global health and U.S. standing abroad.
The Council on Foreign Relations' David Rockefeller Studies Program—CFR's "think tank"—is home to more than seventy full-time, adjunct, and visiting scholars and practitioners (called "fellows"). Their expertise covers the world's major regions as well as the critical issues shaping today's global agenda. Download the printable CFR Experts Guide.
The authors argue that the United States has responded inadequately to the rise of Chinese power and recommend placing less strategic emphasis on the goal of integrating China into the international system and more on balancing China's rise.
Campbell evaluates the implications of the Boko Haram insurgency and recommends that the United States support Nigerian efforts to address the drivers of Boko Haram, such as poverty and corruption, and to foster stronger ties with Nigerian civil society.
Learn more about CFR’s mission and its work over the past year in the 2014 Annual Report. The Annual Report spotlights new initiatives, high-profile events, and authoritative scholarship from CFR experts, and includes a message from CFR President Richard N. Haass. Read and download »